Purpose Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors
comprising various breast cancers simply defined by the absence of estrogen receptor …

Triple-negative breast cancer, so called because it lacks expression of the estrogen
receptor, progesterone receptor, and HER2, is often, but not always, a basal-like breast …

This Review outlines the understanding and management of triple-negative breast cancer
(TNBC). TNBC shares morphological and genetic abnormalities with basal-like breast …

Background Recent studies showed preliminary data on associations of MRI-based imaging
phenotypes of breast tumours with breast cancer molecular, genomic, and related …

Triple-negative breast cancer (TNBC) is defined by a lack of expression of both estrogen
and progesterone receptor as well as human epidermal growth factor receptor 2. It is …

The aim of breast MRI is to obtain a reliable evaluation of any lesion within the breast. It is
currently always used as an adjunct to the standard diagnostic procedures of the breast, ie …

The analysis of the causes that have given rise to a change in tendency in the incidence and
mortality rates of breast cancer in the last few decades generates important revelations …

Triple-negative breast cancers (TNBC), characterized by absence of estrogen receptor (ER),
progesterone receptor (PR) and lack of overexpression of human epidermal growth factor …

Simple Summary Triple-negative breast cancer (TNBC) is a highly aggressive subtype of
breast cancer that cannot be treated with endocrine therapy and Her2-targeted therapy …

Purpose To evaluate the relevance of breast cancer subtypes for magnetic resonance
imaging (MRI) markers for monitoring of therapy response during neoadjuvant …